Register for the webinar here: https://jji.jnj/fundraising
‍
The Dos & Don’ts of Fundraising
Insights from Viva BioInnovator
9:00AM – 10:00AM China Standard Time
5:00PM – 6:00PM Pacific Time (7 Dec)
8:00PM – 9:00PM Eastern Time (7 Dec)
‍

Capital is the crux of a start-up’s success, but fundraising can often be the trickiest part to navigate as an early-stage innovator. Looking for help? We’ve got experts in to share their experience via some simple “dos and don’ts” with the aim to help you on your way to fundraising.

Join us as we seek advice from Johnson & Johnson Innovation – JLABS’ Investor Hub member, Viva BioInnovator, as well residents from the JLABS @ Shanghai portfolio from all walks of fundraising life to share their top tips.

Speaking on the panel will be:
‍
Dr. Han Dai - CBO, Viva Biotech and Head of Investment, Viva BioInnovator - Before this role, Han was Senior Director of New Ventures at Johnson & Johnson Innovation, responsible for developing and implementing Innovation strategies, creating a deep and credible network with innovators and entrepreneurs. Prior to that, he held multiple roles with increasing responsibilities as Scientific Leader and GSK Fellow of Protein Degradation DPU/Future Pipeline Discovery team at GlaxoSmithKline US headquarter. Han has ~20 years’ experience in the pharma/biotech industry with track records of successful leadership in small molecule & biologics drug discovery & development and high-profile publications
‍
Chloe Kamps - Alliance Manager, Viva BioInnovator - Chloe previously worked in the Florida Senate, where she acted as a legislative aide and office manager focusing on policy review for regulated industries. She went on to work in the nonprofit sector as a community organizer and lobbyist advocating for growth and development of the nonprofit sector. Chloe then moved to the private sector, where she worked for a biotech fund in investor relations before starting with VBI in 2018 where she focuses on the identification of new portfolio companies and building

‍